Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Sol-Gel Technologies - 6 Year Stock Split History | SLGL

Stock split history for Sol-Gel Technologies since 2018. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
  
Sol-Gel Technologies Annual Stock Splits
Sol-Gel Technologies Quarterly Stock Splits
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.025B $0.002B
Sol-Gel Technologies Ltd.is a clinical-stage dermatology company. It focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. Its product candidates include VERED for the treatment of papulopustular rosacea, TWIN and SIRS-T for the treatment of acne vulgaris, which are in its clinical stage. Sol-Gel Technologies Ltd.is based in Israel.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $14.328B 5.17
Dr Reddy's Laboratories (RDY) India $11.833B 18.71
Aspen Pharmacare (APNHY) South Africa $5.172B 0.00
BridgeBio Pharma (BBIO) United States $4.387B 0.00
Bausch Health Cos (BHC) Canada $3.143B 2.45
Amphastar Pharmaceuticals (AMPH) United States $1.889B 12.93
Supernus Pharmaceuticals (SUPN) United States $1.580B 0.00
Taysha Gene Therapies (TSHA) United States $0.451B 0.00
Generation Bio (GBIO) United States $0.185B 0.00
Assembly Biosciences (ASMB) United States $0.073B 0.00
Personalis (PSNL) United States $0.061B 0.00
Acasti Pharma (ACST) Canada $0.029B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00
Teligent (TLGT) United States $0.000B 0.00